General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Novartis Annual Results 2014
A consistent focus on three core priorities – innovation, growth and productivity – guides every aspect of our long-term strategy. In the fourth quarter, we made significant progress in each of these areas.
Featured news:
  • 18-Dec-2014 Expanding access to healthcare. Learn more »

  • 18-Dec-2014 Talking to: Juergen Brokatzky-Geiger, Global Head of Corporate Responsibility at Novartis. Learn more »

  • 03-Dec-2014 Safety and efficacy of Fluad vaccinations in Italy. Learn more »

RECENT STORIES

VIDEO

   

Stock chart